Pharma Equity (Denmark) Price on December 2, 2024
PEG Stock | 0.14 0.01 6.67% |
If you're considering investing in Pharma Stock, it is important to understand the factors that can impact its price. As of today, the current price of Pharma Equity stands at 0.14, as last reported on the 3rd of December, with the highest price reaching 0.15 and the lowest price hitting 0.14 during the day. Pharma Equity Group maintains Sharpe Ratio (i.e., Efficiency) of -0.15, which implies the firm had a -0.15% return per unit of risk over the last 3 months. Pharma Equity Group exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pharma Equity's Coefficient Of Variation of (561.34), risk adjusted performance of (0.13), and Variance of 23.9 to confirm the risk estimate we provide.
Pharma Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Pharma |
Sharpe Ratio = -0.15
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | PEG |
Estimated Market Risk
4.76 actual daily | 42 58% of assets are more volatile |
Expected Return
-0.71 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.15 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Pharma Equity is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pharma Equity by adding Pharma Equity to a well-diversified portfolio.
Pharma Equity Valuation on December 2, 2024
It is possible to determine the worth of Pharma Equity on a given historical date. On December 2, 2024 Pharma was worth 0.15 at the beginning of the trading date compared to the closed value of 0.14. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Pharma Equity stock. Still, in general, we apply an absolute valuation method to find Pharma Equity's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Pharma Equity where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Pharma Equity's related companies.
Open | High | Low | Close | Volume | |
0.15 | 0.15 | 0.14 | 0.15 | 671,691 | |
12/02/2024 | 0.15 | 0.15 | 0.14 | 0.14 | 1,729,738 |
0.15 | 0.15 | 0.14 | 0.14 | 0.00 |
Backtest Pharma Equity | | | Pharma Equity History | Previous | Next |
Pharma Equity Trading Date Momentum on December 2, 2024
On December 03 2024 Pharma Equity Group was traded for 0.14 at the closing time. The maximum traded price for the trading interval was 0.15 and the lowest daily price was 0.14 . There was no trading activity during the period 0.0. Lack of trading volume on 3rd of December 2024 did not cause price change. The trading delta at closing time to the closing price today is 7.14% . |
Price Boundaries
Pharma Equity Period Price Range
Low | December 3, 2024
| High |
0.00 | 0.00 |
Pharma Equity Group cannot be verified against its exchange. Please verify the symbol is currently traded on Copenhagen Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Pharma Equity December 3, 2024 Market Strength
Market strength indicators help investors to evaluate how Pharma Equity stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pharma Equity shares will generate the highest return on investment. By undertsting and applying Pharma Equity stock market strength indicators, traders can identify Pharma Equity Group entry and exit signals to maximize returns
Pharma Equity Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Pharma Equity's price direction in advance. Along with the technical and fundamental analysis of Pharma Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Pharma to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.